Authors
Loading...
Research demonstrates altered lymphotoxin signaling impacts myeloid progenitor differentiation in AML, suggesting new therapeutic targets.
Yunqing Liu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: